The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Third consensus on medical treatment of metastatic breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Genomic signatures to guide the use of chemotherapeutics
Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1491 · Cited by 593
RetractedSlamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 3×
“The risk for the development of CHF increases with advanced age and concurrent therapy with trastuzumab and anthracyclines [85].”
BackgroundTargeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Self-citationGradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A., et al. (2006) · Nature · doi:10.1038/nature04296 · Cited by 2,032
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Self-citationO’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487 · cited 1×
“Based upon scientific evidence causally linking the use of HRT to the development of breast cancer [164, 165], the use of HRT in MBC is strongly discouraged, as HRT may stimulate growth of hormone receptor-positive cancers.”
BackgroundMiller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jänicke, F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2596 · Cited by 1,015
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
Hillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm271 · Cited by 944
Ovarian cancer and hormone replacement therapy in the Million Women Study
Beral, V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60534-0 · Cited by 937
Triple-negative breast cancer: therapeutic options
Cleator, S., Heller, W., & Coombes, R. C. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70074-8 · Cited by 882
Rosen, L. S., Gordon, D., Kaminski, M., Howell, A., Belch, A., Mackey, J., Apffelstaedt, J., Hussein, M. A., Coleman, R. E., Reitsma, D. J., et al. (2003) · Cancer · doi:10.1002/cncr.11701 · Cited by 873
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.558 · Cited by 858
Bonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Self-citationCameron, D., Casey, M., Press, M., Lindquist, D., Pienkowski, T., Romieu, C. G., Chan, S., Jagiello-Gruszfeld, A., Kaufman, B., Crown, J., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9885-0 · Cited by 794
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jaenicke, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.194 · Cited by 746
Bennett, C. L. (2008) · JAMA · doi:10.1001/jama.299.8.914 · Cited by 731
Sledge, G. W., Neuberg, D., Bernardo, P., Ingle, J. N., Martino, S., Rowinsky, E. K., & Wood, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.013 · Cited by 707
Trends in Breast Cancer by Race and Ethnicity: Update 2006
Smigal, C., Jemal, A., Ward, E., Cokkinides, V., Smith, R., Howe, H. L., & Thun, M. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.3.168 · Cited by 704
Howell, A., Robertson, J. F. R., Quaresma Albano, J., Aschermannova, A., Mauriac, L., Kleeberg, U. R., Vergote, I., Erikstein, B., Webster, A., & Morris, C. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.057 · Cited by 671
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
Leyland-Jones, B., Semiglazov, V., Pawlicki, M., Pienkowski, T., Tjulandin, S., Manikhas, G., Makhson, A., Roth, A., Dodwell, D., Baselga, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.150 · Cited by 668
Lipton, A., Theriault, R. L., Hortobagyi, G. N., Simeone, J., Knight, R. D., Mellars, K., Reitsma, D. J., Heffernan, M., & Seaman, J. J. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1082::aid-cncr20>3.0.co;2-z · Cited by 665
Osborne, C. K., Pippen, J., Jones, S. E., Parker, L. M., Ellis, M., Come, S., Gertler, S. Z., May, J. T., Burton, G., Dimery, I., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.058 · Cited by 642
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Burris, H. A., Hurwitz, H. I., Dees, E. C., Dowlati, A., Blackwell, K. L., O'Neil, B., Marcom, P. K., Ellis, M. J., Overmoyer, B., Jones, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.584 · Cited by 619
Safra, T., Muggia, F., Jeffers, S., Tsao-Wei, D. D., Groshen, S., Lyass, O., Henderson, R., Berry, G., & Gabizon, A. (2000) · Annals of Oncology · doi:10.1023/a:1008365716693 · Cited by 618
Theriault, R. L., Lipton, A., Hortobagyi, G. N., Leff, R., Glück, S., Stewart, J. F., Costello, S., Kennedy, I., Simeone, J., Seaman, J. J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.846 · Cited by 604
Seidman, A. D., Berry, D., Cirrincione, C., Harris, L., Muss, H., Marcom, P. K., Gipson, G., Burstein, H., Lake, D., Shapiro, C. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6699 · Cited by 594
Self-citationBonneterre, J., Buzdar, A., Nabholtz, J.-M. A., Robertson, J. F. R., Th�rlimann, B., von Euler, M., Sahmoud, T., Webster, A., Steinberg, M., & Arimidex Writing Committee on behalf of the Investigators Committee Members (2001) · Cancer · doi:10.1002/1097-0142(20011101)92:9<2247::aid-cncr1570>3.0.co;2-y · Cited by 574
Self-citationPaterson, A. H., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J., & Ashley, S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.59 · Cited by 557
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
Jones, S. E., Erban, J., Overmoyer, B., Budd, G. T., Hutchins, L., Lower, E., Laufman, L., Sundaram, S., Urba, W. J., Pritchard, K. I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.027 · Cited by 547
Kohno, N., Aogi, K., Minami, H., Nakamura, S., Asaga, T., Iino, Y., Watanabe, T., Goessl, C., Ohashi, Y., & Takashima, S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.116 · Cited by 546
Aapro, M. S., Cameron, D. A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G. H., Tjan-Heijnen, V. C., Walewski, J., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.002 · Cited by 539
Self-citationKhatcheressian, J. L., Wolff, A. C., Smith, T. J., Grunfeld, E., Muss, H. B., Vogel, V. G., Halberg, F., Somerfield, M. R., & Davidson, N. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8575 · Cited by 535
Harris, L., Batist, G., Belt, R., Rovira, D., Navari, R., Azarnia, N., Welles, L., Winer, E., & TLC D‐99 Study Group (2002) · Cancer · doi:10.1002/cncr.10201 · Cited by 512
Colleoni, M., Rocca, A., Sandri, M. T., Zorzino, L., Masci, G., Nolè, F., Peruzzotti, G., Robertson, C., Orlando, L., Cinieri, S., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf013 · Cited by 496
Burstein, H. J., Elias, A. D., Rugo, H. S., Cobleigh, M. A., Wolff, A. C., Eisenberg, P. D., Lehman, M., Adams, B. J., Bello, C. L., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5375 · Cited by 489
Self-citationThomas, E. S., Gomez, H. L., Li, R. K., Chung, H.-C., Fein, L. E., Chan, V. F., Jassem, J., Pivot, X. B., Klimovsky, J. V., de Mendoza, F. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6557 · Cited by 481
Self-citationRobert, N., Leyland-Jones, B., Asmar, L., Belt, R., Ilegbodu, D., Loesch, D., Raju, R., Valentine, E., Sayre, R., Cobleigh, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1764 · Cited by 479
Buzdar, A. U., Valero, V., Ibrahim, N. K., Francis, D., Broglio, K. R., Theriault, R. L., Pusztai, L., Green, M. C., Singletary, S. E., Hunt, K. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1345 · Cited by 475
Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm442 · Cited by 457
Self-citationLin, N. U., Carey, L. A., Liu, M. C., Younger, J., Come, S. E., Ewend, M., Harris, G. J., Bullitt, E., Van den Abbeele, A. D., Henson, J. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3588 · Cited by 456
Self-citationThomas, E. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5019 · Cited by 428
Klijn, J. G. M., Blamey, R. W., Boccardo, F., Tominaga, T., Duchateau, L., & Sylvester, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.343 · Cited by 425
Baselga, J., Carbonell, X., Castañeda-Soto, N.-J., Clemens, M., Green, M., Harvey, V., Morales, S., Barton, C., & Ghahramani, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.014 · Cited by 425
Albain, K. S., Nag, S. M., Calderillo-Ruiz, G., Jordaan, J. P., Llombart, A. C., Pluzanska, A., Rolski, J., Melemed, A. S., Reyes-Vidal, J. M., Sekhon, J. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9362 · Cited by 425
Howell, A., Robertson, J. F. R., Abram, P., Lichinitser, M. R., Elledge, R., Bajetta, E., Watanabe, T., Morris, C., Webster, A., Dimery, I., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.112 · Cited by 421
Di Leo, A., Gomez, H. L., Aziz, Z., Zvirbule, Z., Bines, J., Arbushites, M. C., Guerrera, S. F., Koehler, M., Oliva, C., Stein, S. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2578 · Cited by 418
Buzdar, A. U., Jonat, W., Howell, A., Jones, S. E., BLOMQVIST, C. P., Vogel, C. L., EIERMANN, W., Wolter, J. M., Steinberg, M., Webster, A., et al. (1998) · PubMed · Cited by 417
Self-citationBody, J.-J., Diel, I. J., Lichinitser, M. R., Kreuser, E. D., Dornoff, W., Gorbunova, V. A., Budde, M., & Bergström, B. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg367 · Cited by 413
Buzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2000 · Cited by 406
Nabholtz, J.-M., Falkson, C., Campos, D., Szanto, J., Martin, M., Chan, S., Pienkowski, T., Zaluski, J., Pinter, T., Krzakowski, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.040 · Cited by 384
Nabholtz, J. M., Gelmon, K., Bontenbal, M., Spielmann, M., Catimel, G., Conte, P., Klaassen, U., Namer, M., Bonneterre, J., Fumoleau, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.6.1858 · Cited by 380
Self-citationSeidman, A. D., Hudis, C. A., Albanell, J., Albanel, J., Tong, W., Tepler, I., Currie, V, Moynahan, M. E., Theodoulou, M., Gollub, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3353 · Cited by 378
Buzdar, A., Douma, J., Davidson, N., Elledge, R., Morgan, M., Smith, R., Porter, L., Nabholtz, J., Xiang, X., & Brady, C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3357 · Cited by 365
Spector, N. L., Xia, W., Burris, H., Hurwitz, H., Dees, E. C., Dowlati, A., O'Neil, B., Overmoyer, B., Marcom, P. K., Blackwell, K. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.157 · Cited by 362
Bisphosphonates for breast cancer
Pavlakis, N., & Stockler, M. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474 · Cited by 360
Self-citationMass, R. D., Press, M. F., Anderson, S., Cobleigh, M. A., Vogel, C. L., Dybdal, N., Leiberman, G., & Slamon, D. J. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.026 · Cited by 359
Self-citationSchneider, B. P., & Miller, K. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.017 · Cited by 350
Burstein, H. J., Harris, L. N., Marcom, P. K., Lambert-Falls, R., Havlin, K., Overmoyer, B., Friedlander, R. J., Gargiulo, J., Strenger, R., Vogel, C. L., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.018 · Cited by 342
Self-citationGomez, H. L., Doval, D. C., Chavez, M. A., Ang, P. C.-S., Aziz, Z., Nag, S., Ng, C., Franco, S. X., Chow, L. W. C., Arbushites, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.0590 · Cited by 338
Rosen, L. S., Gordon, D. H., Dugan, W., Major, P., Eisenberg, P. D., Provencher, L., Kaminski, M., Simeone, J., Seaman, J., Chen, B., et al. (2004) · Cancer · doi:10.1002/cncr.11892 · Cited by 335
Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.7960 · Cited by 335
Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
Brewster, A. M., Hortobagyi, G. N., Broglio, K. R., Kau, S.-W., Santa-Maria, C. A., Arun, B., Buzdar, A. U., Booser, D. J., Valero, V., Bondy, M., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn233 · Cited by 331
Rizzo, J. D., Somerfield, M. R., Hagerty, K. L., Seidenfeld, J., Bohlius, J., Bennett, C. L., Cella, D. F., Djulbegovic, B., Goode, M. J., Jakubowski, A. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3396 · Cited by 327
Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2234 · Cited by 316
Jassem, J., Pieńkowski, T., Płuzańska, A., Jelic, S., Gorbunova, V., Mrsic-Krmpotic, Z., Berzins, J., Nagykalnai, T., Wigler, N., Renard, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1707 · Cited by 308
Self-citationSingle agent versus combination chemotherapy for metastatic breast cancer
Carrick, S., Parker, S., Thornton, C., Ghersi, D., Simes, J., & Wilcken, N. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub3 · Cited by 305
Self-citationO’Shaughnessy, J. A., Blum, J., Moiseyenko, V., Jones, S. E., Miles, D., Bell, D., Rosso, R., Mauriac, L., Osterwalder, B., Burger, H.-U., et al. (2001) · Annals of Oncology · doi:10.1023/a:1012281104865 · Cited by 304
Burris, H. A. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_3-10 · Cited by 295
Leyland-Jones, B., Gelmon, K., Ayoub, J.-P., Arnold, A., Verma, S., Dias, R., & Ghahramani, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.109 · Cited by 293
Babiera, G. V., Rao, R., Feng, L., Meric-Bernstam, F., Kuerer, H. M., Singletary, S. E., Hunt, K. K., Ross, M. I., Gwyn, K. M., Feig, B. W., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.033 · Cited by 284
Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression
Tripathy, D., Slamon, D. J., Cobleigh, M., Arnold, A., Saleh, M., Mortimer, J. E., Murphy, M., & Stewart, S. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.557 · Cited by 280
Kendall, A., Dowsett, M., Folkerd, E., & Smith, I. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj127 · Cited by 277
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
Blanchard, D. K., Shetty, P. B., Hilsenbeck, S. G., & Elledge, R. M. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181656d32 · Cited by 254
Multicenter Phase II Trial of Weekly Paclitaxel in Women With Metastatic Breast Cancer
Perez, E. A., Vogel, C. L., Irwin, D. H., Kirshner, J. J., & Patel, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4216 · Cited by 250
Self-citationKlijn, J. G. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.903 · Cited by 248
Elkins, G., Marcus, J., Stearns, V., Perfect, M., Rajab, M. H., Ruud, C., Palamara, L., & Keith, T. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6389 · Cited by 245
Bisphosphonates for breast cancer
Pavlakis, N., Schmidt, R. L., & Stockler, M. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474.pub2 · Cited by 244
Self-citationSafety of intravenous and oral bisphosphonates and compliance with dosing regimens
Conte, P., & Guarneri, V. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90004-28 · Cited by 241 · cited 3×
“In addition, dose- and infusion ratedependent effects of bisphosphonates on renal function have been reported [148].”
BackgroundInfluentialDental management of patients receiving oral bisphosphonate therapy
(2006) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2006.0355 · Cited by 232
Paridaens, R., Dirix, L., Lohrisch, C., Beex, L., Nooij, M., Cameron, D., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg362 · Cited by 230
Piccart-Gebhart, M. J., Burzykowski, T., Buyse, M., Sledge, G., Carmichael, J., Lück, H.-J., Mackey, J. R., Nabholtz, J.-M., Paridaens, R., Biganzoli, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8399 · Cited by 216
Self-citationBurstein, H. J., Keshaviah, A., Baron, A. D., Hart, R. D., Lambert‐Falls, R., Marcom, P. K., Gelman, R., & Winer, E. P. (2007) · Cancer · doi:10.1002/cncr.22885 · Cited by 214
Self-citationKeller, A. M., Mennel, R. G., Georgoulias, V. A., Nabholtz, J.-M., Erazo, A., Lluch, A., Vogel, C. L., Kaufmann, M., von Minckwitz, G., Henderson, I. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.157 · Cited by 214
Self-citationMiles, D., Chan, A., Romieu, G., Dirix, L. Y., Cortes, J., Pivot, X., Tomczak, P., Taran, T., Harbeck, N., & Steger, G. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.lba1011 · Cited by 213
Bajetta, E., Procopio, G., Celio, L., Gattinoni, L., Della Torre, S., Mariani, L., Catena, L., Ricotta, R., Longarini, R., Zilembo, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.167 · Cited by 207
Burstein, H. J., Storniolo, A. M., Franco, S., Forster, J., Stein, S., Rubin, S., Salazar, V. M., & Blackwell, K. L. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm601 · Cited by 203
Self-citationAn open randomised trial of second-line endocrine therapy in advanced breast cancer
Rose, C., Vtoraya, O., Pluzanska, A., Davidson, N., Gershanovich, M., Thomas, R., Johnson, S., Caicedo, J. J., Gervasio, H., Manikhas, G., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00630-0 · Cited by 192
Body, J.-J., Diel, I. J., Bell, R., Pecherstorfer, M., Lichinitser, M. R., Lazarev, A. F., Tripathy, D., & Bergström, B. (2004) · Pain · doi:10.1016/j.pain.2004.07.011 · Cited by 190
Martín, M., Ruiz, A., Muñoz, M., Balil, A., García-Mata, J., Calvo, L., Carrasco, E., Mahillo, E., Casado, A., García-Saenz, J. Á., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70041-4 · Cited by 187
Colleoni, M., Orlando, L., Sanna, G., Rocca, A., Maisonneuve, P., Peruzzotti, G., Ghisini, R., Sandri, M. T., Zorzino, L., Nolè, F., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj066 · Cited by 186
Weitzman, R., Sauter, N., Eriksen, E. F., Tarassoff, P. G., Lacerna, L. V., Dias, R., Altmeyer, A., Csermak-Renner, K., McGrath, L., Lantwicki, L., et al. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.12.005 · Cited by 185
Pegram, M. D., & Slamon, D. J. (1999) · PubMed · Cited by 185
Isola, J., Tanner, M., Forsyth, A., Cooke, T. G., Watters, A. D., & Bartlett, J. M. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0428-03 · Cited by 181
Nabholtz, J. M., Bonneterre, J., Buzdar, A., Robertson, J. F. R., & Thürlimann, B. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00326-5 · Cited by 176
Self-citationOral clodronate in breast cancer patients with bone metastases: a randomized study
Kristensen, B., Ejlertsen, B., Groenvold, M., Hein, S., Loft, H., & Mouridsen, H. T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00507.x · Cited by 176
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
Wilcken, N., Hornbuckle, J., & Ghersi, D. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002747 · Cited by 165
Self-citationHowell, A., Pippen, J., Elledge, R. M., Mauriac, L., Vergote, I., Jones, S. E., Come, S. E., Osborne, C. K., & Robertson, J. F. R. (2005) · Cancer · doi:10.1002/cncr.21163 · Cited by 163
Carey, L. A., Rugo, H. S., Marcom, P. K., Irvin, W., Ferraro, M., Burrows, E., He, X., Perou, C. M., & Winer, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.1009 · Cited by 163
Albain, K. S., Nag, S., Calderillo-Ruiz, G., Jordaan, J. P., Llombart‐Cussac, A., Pluzanska, A., Pawlicki, M., Melemed, A. S., O’Shaughnessy, J., & Reyes, J. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.510 · Cited by 161
Tabernero, J. M., Climent, M. A., Lluch, A. M., Albanell, J., Vermorken, J. B., Barnadas, A., Anton, A., Laurent, C., Mayordomo, J. I., Estaun, N., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh349 · Cited by 156
O’Shaughnessy, J., Blackwell, K. L., Burstein, H. J., Storniolo, A. M., Sledge, G. W., Baselga, J. M., Koehler, M. T., Laabs, S., Florance, A. M., & Roychowdhury, D. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.1015 · Cited by 154
Self-citationCapecitabine and Trastuzumab in Heavily Pretreated Metastatic Breast Cancer
Bartsch, R., Wenzel, C., Altorjai, G., Pluschnig, U., Rudas, M., Mader, R. M., Gnant, M., Zielinski, C. C., & Steger, G. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9776 · Cited by 150
Self-citationCarlson, R. W., Hudis, C. A., & Pritchard, K. I. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0082 · Cited by 142
Jahanzeb, M., Mortimer, J. E., Yunus, F., Irwin, D. H., Speyer, J. L., Koletsky, A. J., Klein, P., Sabir, T., & Kronish, L. E. (2002) · The Oncologist · doi:10.1634/theoncologist.7-5-410 · Cited by 142
Thurlimann, B. J. K., Paridaens, R., Serin, D., Bonneterre, J. M., Roche, H. H., Murray, R., di Salle, E., Lanzalone, S., Zurlo, M. G., & Piscitelli, G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00283-9 · Cited by 141
Self-citationChia, S., Clemons, M. J., Martin, L. A. K., Rodgers, A., Gelmon, K. A., Pond, G. R., & Panasci, L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8331 · Cited by 138
Boccardo, F., RUBAGOTTI, A., Perrotta, A., AMOROSO, D., Balestrero, M., Matteis, A. D., Zola, P., Sismondi, P., Francini, G., Petrioli, R., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058837 · Cited by 134
Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy
Wulfkuhle, J. D., Speer, R., Pierobon, M., Laird, J., Espina, V. A., Deng, J., Mammano, E., Yang, S. X., Swain, S. M., Nitti, D., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr7008127 · Cited by 133
Estrogen Receptor Analysis for Breast Cancer
Diaz, L. K., & Sneige, N. (2005) · Advances in Anatomic Pathology · doi:10.1097/00125480-200501000-00003 · Cited by 127
Buzdar, A. U., Smith, R. A., Vogel, C. L., Bonomi, P., Keller, A. M., Favis, G., Mulagha, M. T., Cooper, J., & for the Multi-Institutional Trialist Collaborative Study Group (1996) · Cancer · Cited by 118
Self-citationSingle agent versus combination chemotherapy for metastatic breast cancer
Carrick, S. E., Parker, S., Thornton, C. E., Ghersi, D., Simes, J. R., & Wilcken, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003372.pub2 · Cited by 118
Self-citationO’Shaughnessy, J., Vukelja, S., Marsland, T., Kimmel, G. T., Ratnam, S., & Pippen, J. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.019 · Cited by 114
Drug Insight: VEGF as a therapeutic target for breast cancer
Schneider, B. P., & Sledge, G. W. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0740 · Cited by 114
Goss, P. E., Winer, E. P., Tannock, I. F., & Grou, L. H. S. O. B. O. T. N. A. V. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.52 · Cited by 111
Schwartzberg, L. S., Yee, L., Senecal, F. M., Charu, V., Tomita, D. K., Wallace, J. F., & Rossi, G. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-696 · Cited by 104
Jonat, W., Kaufmann, M., Blamey, R. W., Howell, A., Collins, J. P., Coates, A., EIERMANN, W., Jänicke, F., Njordenskold, B., Forbes, J., et al. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00415-2 · Cited by 103
Feher, O., Vodvarka, P., Jassem, J., Morack, G., Advani, S. H., Khoo, K. S., Doval, D. C., Ermisch, S., Roychowdhury, D., Miller, M. A., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi181 · Cited by 101
Self-citationA systematic review of taxane-containing regimens for metastatic breast cancer
Ghersi, D., Wilcken, N., & Simes, R. J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602680 · Cited by 99
Self-citationManagement of menopausal symptoms in patients with breast cancer: an evidence-based approach
Hickey, M., Saunders, C. M., & Stuckey, B. G. A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70316-8 · Cited by 94
Falkson, G., Gelman, R. S., Pandya, K. J., Osborne, C. K., Tormey, D. C., Cummings, F. J., Sledge, G. W., & Abeloff, M. D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1669 · Cited by 92
Second consensus on medical treatment of metastatic breast cancer
Beslija, S., Bonneterre, J. M., Burstein, H. J., Cocquyt, V. F. J., Gnant, M., Goodwin, P. J., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl155 · Cited by 92
Self-citationDemicheli, R., Hrushesky, W. J. M., Retsky, M. W., Bonadonna, G., & Valagussa, P. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9279-2 · Cited by 90
Thurlimann, B. J. K., Robertson, J. F. R., Nabholtz, J., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00602-6 · Cited by 89
Ali, S. M., Carney, W. P., Esteva, F. J., Fornier, M. N., Harris, L. N., Köstler, W. J., Lotz, J., Lüftner, D., Pichon, M. F., & Lipton, A. (2008) · Cancer · doi:10.1002/cncr.23689 · Cited by 87
Self-citationBennett, C. L., Weeks, J. C., Somerfield, M. R., Feinglass, J. M., & Smith, T. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3676 · Cited by 85
Lack of Benefit of Maintenance Paclitaxel in First-Line Chemotherapy in Metastatic Breast Cancer
Gennari, A., Amadori, D., Lena, M. D., Nanni, O., Bruzzi, P., Lorusso, V., Manzione, L., & Conte, P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1812 · Cited by 81
Glaspy, J. A., Vadhan‐Raj, S., Patel, R., Bosserman, L. D., Hu, E. H.-L., Lloyd, R. E., Boccia, R. V., Tomita, D. K., & Rossi, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8570 · Cited by 80
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer
Dufresne, A., Pivot, X. B., Tournigand, C., Facchini, T., Altweeg, T., Chaigneau, L., & de Gramont, A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9550-7 · Cited by 77
von Minckwitz, G., Zielinski, C., Maarteense, E., Vogel, P., Schmidt, M., Eidtmann, H., Čufer, T., de Jongh, F. E., Kaufmann, M., & Loibl, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.1025 · Cited by 76
Self-citationJohnston, S. R. D., Pegram, M. D., Press, M. F., Pippen, J., Pivot, X. B., Gómez, H., Florance, A. M., O’Rourke, L., & Maltzman, J. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-46 · Cited by 66
Differentiating Proteomic Biomarkers in Breast Cancer by Laser Capture Microdissection and MALDI MS
Sanders, M. E., Dias, E. C., Xu, B. J., Mobley, J. A., Billheimer, D. D., Röder, H., Grigorieva, J., Dowsett, M., Arteaga, C. L., & Caprioli, R. M. (2008) · Journal of Proteome Research · doi:10.1021/pr7008109 · Cited by 64
Bartsch, R., Wenzel, C., Hussian, D., Pluschnig, U., Sevelda, U., Koestler, W. J., Altorjai, G., Locker, G. J., Mader, R. M., Zielinski, C. C., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-63 · Cited by 54
Self-citationHauser‐Kronberger, C., & Dandachi, N. (2004) · The Histochemical Journal · doi:10.1007/s10735-004-2186-6 · Cited by 51
Central nervous system metastases in breast cancer patients administered trastuzumab
Duchnowska, R., & Szczylik, C. A. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.04.008 · Cited by 49
Advances of MUC1 as a target for breast cancer immunotherapy.
Yang, E., Hu, X. F., & Xing, P. (2007) · PubMed · doi:10.14670/hh-22.905 · Cited by 47
Rabaglio, M., Aebi, S. P., & Castiglione‐Gertsch, M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70317-0 · Cited by 46
Pegram, M. D., Forbes, J., Pieńkowski, T., Valero, V., EIERMANN, W., von Minckwitz, G., Martín, M., Crown, J. P., Taupin, H., & Slamon, D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.lba1008 · Cited by 46
Bartsch, R., Wenzel, C., Gampenrieder, S. P., Pluschnig, U., Altorjai, G., Rudas, M., Mader, R. M., Dubsky, P. C., Rottenfusser, A., Gnant, M., et al. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0682-1 · Cited by 43
Self-citationParton, M., & Smith, I. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3016 · Cited by 38
Biganzoli, L., Coleman, R. E., Minisini, A. M., Hamilton, A. L., Aapro, M., Therasse, P., Mottino, G., Bogaerts, J., & Piccart, M. J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.008 · Cited by 38
Venturini, M., Bighin, C., Monfardini, S., Cappuzzo, F., Olmeo, N. A., Durando, A., Puglisi, F., Nicoletto, O., Lambiase, A., & Mastro, L. D. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9030-x · Cited by 31
Löffler‐Ragg, J., Skvortsov, S., Sarg, B., Skvortsova, I., Witsch‐Baumgartner, M., Mueller, D., Lindner, H. H., & Zwierzina, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.014 · Cited by 31
Self-citationRiccardi, A., Tinelli, C., Brugnatelli, S., Pugliese, P., Giardina, V., Giordano, M., Danova, M., Richetti, A., Fava, S., Rinaldi, E., et al. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.4.769 · Cited by 29
Gradishar, W., Krasnojon, D., Cheporov, S. V., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.1032 · Cited by 29
Options for the Treatment of Patients with Taxane-Refractory Metastatic Breast Cancer
Overmoyer, B. A. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.s.002 · Cited by 27
Senecal, F. M., Yee, L., Gabrail, N. Y., Charu, V., Tomita, D. K., Rossi, G., & Schwartzberg, L. S. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.050 · Cited by 27
Breast Cancer Survivors and Hot Flashes: The Search for Nonhormonal Treatments
Avis, N. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2170 · Cited by 24
Perspectives on the development of a therapeutic HER-2 cancer vaccine
Renard, V., & Leach, D. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.060 · Cited by 22
Management of Postmenopausal Symptoms in Breast Cancer Survivors
BRUNO, D., & Feeney, K. J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.08.010 · Cited by 18
Zielinski, C. C., Awada, A. H., Cameron, D., Čufer, T., Martín, M., & Aapro, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.11.024 · Cited by 15
Self-citationEllis, M., Dehdahti, F., Kommareddy, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-16 · Cited by 10
Consensus on medical treatment of non-small cell lung cancer
Thatcher, N. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00259-3 · Cited by 10
Ixabepilone for the Treatment of Taxane-Refractory Breast Cancer
Moulder, S. L. (2008) · Future Oncology · doi:10.2217/14796694.4.3.333 · Cited by 3
Cited by
Champion, H. C., Michelakis, E. D., & Hassoun, P. M. (2009) · Circulation · doi:10.1161/circulationaha.106.674028 · Cited by 468
Prognostic factors in 1038 women with metastatic breast cancer
Largillier, R., Ferrero, J.-M., Doyen, J., Barriere, J., Namer, M., Mari, V., Courdi, A., Hannoun-Levi, J. M., Ettore, F., Birtwisle-Peyrottes, I., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn424 · Cited by 373
Sinn, B. V., Fu, C., Lau, R., Litton, J., Tsai, T.-H., Murthy, R., Tam, A., Andreopoulou, E., Gong, Y., Murthy, R., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0111-0 · Cited by 354
André, F., & Zielinski, C. C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds195 · Cited by 329
Self-citationMetformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Rocha, G. Z., Dias, M. M., Ropelle, E. R., Osório-Costa, F., Rossato, F. A., Vercesi, A. E., Saad, M. J. A., & Carvalheira, J. B. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2243 · Cited by 305
Metadata
- Authors
- Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C. C., & Zwierzina, H.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 20
- Issue
- 11
- Pages
- 1771-1785
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2138361287
- Cited by
- 263
- References
- 172
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.